Showing results (551-560 of 576) with videos related to

Sort By:
Pageof 58
Antimicrobial Agents and Chemotherapy|May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeBelén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT CohortZaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Nature Communications|January 4, 2018
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteriaMark A T Blaskovich, Karl A Hansford, Yujing Gong, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing EnterobacteriaceaeKalisvar Marimuthu, Oon Tek Ng, Benjamin Pei Zhi Cherng, et al.
Science Translational Medicine|November 19, 2020
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsisDavid M P De Oliveira, Lisa Bohlmann, Trent Conroy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing EnterobacteriaceaeZaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
Pageof 58